Khiron Fundamentals

KHRWF -  USA Stock  

USD 0.1  0.0026  2.76%

Khiron Life Sciences fundamentals help investors to digest information that contributes to Khiron Life's financial success or failures. It also enables traders to predict the movement of Khiron OTC Stock. This fundamental analysis module provides a way for investors to measures Khiron Life's intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Khiron Life otc stock. Please note, this module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Khiron Fundamentals 

 
Refresh

Khiron Debt to Equity Analysis

Khiron Life's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
D/E 
 = 
Total Debt 
Total Equity 
More About Debt to Equity | All Equity Analysis

Current Khiron Life Debt to Equity

    
  0.06 %  
Most of Khiron Life's fundamental indicators, such as Debt to Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Khiron Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Compare to competition
According to the company disclosure, Khiron Life Sciences has a Debt to Equity of 0.055%. This is much higher than that of the sector and significantly higher than that of the Debt to Equity industry. The debt to equity for all United States stocks is notably lower than that of the firm.

Khiron Life Sciences Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Khiron Life's current stock value. Our valuation model uses many indicators to compare Khiron Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Khiron Life competition to find correlations between indicators driving Khiron Life's intrinsic value. More Info.
Khiron Life Sciences is currently regarded as number one stock in current ratio category among related companies. It is currently regarded as number one stock in beta category among related companies totaling about  0.55  of Beta per Current Ratio. The ratio of Current Ratio to Beta for Khiron Life Sciences is roughly  1.82 

Khiron Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Khiron Life's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Khiron Life could also be used in its relative valuation, which is a method of valuing Khiron Life by comparing valuation metrics of similar companies.
Khiron Life is currently under evaluation in return on asset category among related companies.

Khiron Fundamentals

About Khiron Life Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Khiron Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Khiron Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Khiron Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America, North America, and Europe. Khiron Life Sciences Corp. was founded in 2017 and is based in Vancouver, Canada. Khiron Life is traded on OTC Exchange in the United States.

Khiron Life Investors Sentiment

The influence of Khiron Life's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Khiron. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - KHRWF

Khiron Life Sciences Investor Sentiment

Macroaxis portfolio users are evenly split in their trading attitude regarding investing in Khiron Life Sciences. What is your trading attitude regarding investing in Khiron Life Sciences? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Khiron Life Sciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Khiron Life Piotroski F Score and Khiron Life Altman Z Score analysis. Note that the Khiron Life Sciences information on this page should be used as a complementary analysis to other Khiron Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for Khiron OTC Stock analysis

When running Khiron Life Sciences price analysis, check to measure Khiron Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Khiron Life is operating at the current time. Most of Khiron Life's value examination focuses on studying past and present price action to predict the probability of Khiron Life's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Khiron Life's price. Additionally, you may evaluate how the addition of Khiron Life to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
The market value of Khiron Life Sciences is measured differently than its book value, which is the value of Khiron that is recorded on the company's balance sheet. Investors also form their own opinion of Khiron Life's value that differs from its market value or its book value, called intrinsic value, which is Khiron Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Khiron Life's market value can be influenced by many factors that don't directly affect Khiron Life Sciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Khiron Life's value and its price as these two are different measures arrived at by different means. Investors typically determine Khiron Life value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Khiron Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.